Key facts
- It has raised $22.0M; the latest was Later Stage VC ($750K) in Oct 2024.
- Notable investors include Elaia Partners, SWEN Capital Partners, Astorg, Aquitaine Science Transfert, Cenitz — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for inHEART
- ·The full record, as it builds
Funding rounds
No funding rounds for inHEART are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About inHEART
Developer of heart imaging device designed for personalized treatment, prevention, and screening for cardiac arrhythmias, heart failure, and stroke. The company's AI-enabled platform transforms preoperative medical images into a digital twin of the patient's heart, enabling cardiologists to plan the procedure and assist in navigating instruments in the patient's heart, substantially reducing procedure duration and failure rates.
- Sector
- Healthcare
- HQ
- Pessac, France
- Founded
- 2017
- Employees
- 50
- Website
- inheartmedical.com/
- Ownership
- Privately Held (backing)
inHEART doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in inHEART shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on inHEART in its N-PORT filings yet. We sweep new filings monthly.